SEM Observation of the Filter after Administration of Blinatumomab: A Possibility of Leakage during Home Administration Using a Portable Infusion Pump

SEM Observation of the Filter after Administration of Blinatumomab: A Possibility of Leakage during Home Administration Using a Portable Infusion Pump

Blinatumomab (Blincyto<sup>®</sup> injection solution) is classified as a bispecific T-cell engaging (BiTE) antibody and is intended for the treatment of relapsed/refractory acute lymphoblastic leukemia. It requires continuous infusion to maintain therapeutic levels. Therefore, it is oft...

Full description

Bibliographic Details
Main Authors: Megumi Takano, Motoki Inoue, Yuko Ikeda, Hidenori Kage, Tohru Inokawa, Kazuhiko Nakadate, Takeo Yasu, Yasumasa Tsuda, Kazumi Goto
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:International Journal of Molecular Sciences
Subjects:
blinatumomab
leakage
continuous infusion
bispecific T-cell engagers
polysorbate 80
filter
Online Access:https://www.mdpi.com/1422-0067/24/6/5729

Internet

https://www.mdpi.com/1422-0067/24/6/5729

Similar Items